Literature DB >> 3365012

Fructosamine or glycated haemoglobin as a measure of diabetic control?

J Allgrove1, B L Cockrill.   

Abstract

Glycated haemoglobin A1 (HbA1c), fructosamine, and total serum proteins were measured in 30 normal and 61 diabetic children. The normal range for HbA1c was 4.7-8.8% and for fructosamine was 0.98-1.88 mmol/l. These were similar to adult normal ranges and there were no significant age differences during childhood. There was a highly significant correlation between HbA1c and fructosamine in the diabetic children but this was lost when only concentrations within the established normal ranges were considered. Adjustment of concentrations of fructosamine for total serum proteins made no difference to the results. Changes in HbA1c and fructosamine were followed in three newly diagnosed patients and in one whose diabetes was getting worse. HbA1c decayed with a half life of 28.7 days and fructosamine decayed with a half life of 16.5 days. Fructosamine concentrations were lower than expected in the patients who were improving and higher than expected in the patient who was deteriorating. It is suggested that while fructosamine is not a direct substitute for HbA1c it may be a useful adjunct in determining whether a patient is worsening or improving in the short term. A change from HbA1c to fructosamine for routine assessment of diabetes while retaining HbA1c on selected occasions would result in some cost savings while retaining the advantages of having both assays available.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3365012      PMCID: PMC1778821          DOI: 10.1136/adc.63.4.418

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  11 in total

1.  [Diabetes mellitus and its degenerative complications: a prospective study of 4,400 patients observed between 1947 and 1973 (author's transl)].

Authors:  J Pirart
Journal:  Diabete Metab       Date:  1977-06

2.  [Diabetes mellitus and its degenerative complications: a prospective study of 4,400 patients observed between 1947 and 1973 (2nd part) (author's transl)].

Authors:  J Pirart
Journal:  Diabete Metab       Date:  1977-09

3.  Clinical use and time relationship of changes in affinity measurement of glycosylated albumin and glycosylated hemoglobin.

Authors:  M Rendell; R Paulsen; S Eastberg; P M Stephen; J L Valentine; C H Smith; J Nierenberg; K Rasbold; D Klenk; P K Smith
Journal:  Am J Med Sci       Date:  1986-07       Impact factor: 2.378

4.  Glycated haemoglobin and glycated plasma protein, a comparative study.

Authors:  I S Ross; A F Mitchell; R E Stroud
Journal:  Clin Chim Acta       Date:  1986-05-15       Impact factor: 3.786

5.  Chronic response of dogs to parathyroid hormone infusion.

Authors:  J A Parsons; B Reit
Journal:  Nature       Date:  1974-07-19       Impact factor: 49.962

6.  Nonenzymatic glucosylation of rat albumin. Studies in vitro and in vivo.

Authors:  J F Day; R W Thornburg; S R Thorpe; J W Baynes
Journal:  J Biol Chem       Date:  1979-10-10       Impact factor: 5.157

7.  [Diabetes mellitus and its degenerative complications: a prospective study of 4,400 patients observed between 1947 and 1973 (3rd and last part) (author's transl)].

Authors:  J Pirart
Journal:  Diabete Metab       Date:  1977-12

8.  Clinical usefulness of estimation of serum fructosamine concentration as a screening test for diabetes mellitus.

Authors:  J R Baker; J P O'Connor; P A Metcalf; M R Lawson; R N Johnson
Journal:  Br Med J (Clin Res Ed)       Date:  1983-09-24

9.  Serum fructosamine and glycated haemoglobin measurements in diabetic control.

Authors:  E J Hindle; G M Rostron; S A Clark; J A Gatt
Journal:  Arch Dis Child       Date:  1986-02       Impact factor: 3.791

10.  Serum fructosamine concentration as measure of blood glucose control in type I (insulin dependent) diabetes mellitus.

Authors:  J R Baker; P A Metcalf; I M Holdaway; R N Johnson
Journal:  Br Med J (Clin Res Ed)       Date:  1985-02-02
View more
  5 in total

1.  Serum fructosamine and retinopathy of prematurity.

Authors:  Senol Bozdag; Serife Suna Oguz; Tulin Gokmen; Zuhal Tunay; Levent Tok; Nurdan Uras; Omer Erdeve; Ugur Dilmen
Journal:  Indian J Pediatr       Date:  2011-07-06       Impact factor: 1.967

2.  Associations of alternative markers of glycemia with hemoglobin A(1c) and fasting glucose.

Authors:  Stephen P Juraschek; Michael W Steffes; Elizabeth Selvin
Journal:  Clin Chem       Date:  2012-09-27       Impact factor: 8.327

3.  The population sizes and global extinction risk of reef-building coral species at biogeographic scales.

Authors:  Andreas Dietzel; Michael Bode; Sean R Connolly; Terry P Hughes
Journal:  Nat Ecol Evol       Date:  2021-03-01       Impact factor: 15.460

Review 4.  Recent Developments in Biomarkers for Diagnosis and Screening of Type 2 Diabetes Mellitus.

Authors:  Margarita Ortiz-Martínez; Mirna González-González; Alexandro J Martagón; Victoria Hlavinka; Richard C Willson; Marco Rito-Palomares
Journal:  Curr Diab Rep       Date:  2022-03-10       Impact factor: 5.430

5.  Effect of type and amount of dietary carbohydrate on biomarkers of glucose homeostasis and C reactive protein in overweight or obese adults: results from the OmniCarb trial.

Authors:  Stephen P Juraschek; Edgar R Miller; Elizabeth Selvin; Vincent J Carey; Lawrence J Appel; Robert H Christenson; Frank M Sacks
Journal:  BMJ Open Diabetes Res Care       Date:  2016-11-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.